Associated Papers
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
Incorvaia L et al.
Cancer Treatment Reviews, 2023
MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC.
Zhuang X et al.
Cell & Bioscience, 2023
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma.
Hu D et al.
Cancer Science, 2022
Select a paper to view details